Edwards Lifesciences Lifepath AAA Graft Fracture Investigation Ongoing
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences is continuing to investigate the cause of fractures detected in the wireform scaffolding of its Lifepath endovascular graft system for treatment of abdominal aortic aneurysms, following discovery of the fractures in two patients treated with the device.